Melatonin as a Potential Adjuvant Treatment for COVID-19 beyond Sleep Disorders.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
11 Aug 2021
Historique:
received: 29 06 2021
revised: 05 08 2021
accepted: 06 08 2021
entrez: 27 8 2021
pubmed: 28 8 2021
medline: 1 9 2021
Statut: epublish

Résumé

Melatonin is registered to treat circadian rhythm sleep-wake disorders and insomnia in patients aged 55 years and over. The essential role of the circadian sleep rhythm in the deterioration of sleep quality during COVID-19 confinement and the lack of an adverse effect of melatonin on respiratory drive indicate that melatonin has the potential to be a recommended treatment for sleep disturbances related to COVID-19. This review article describes the effects of melatonin additional to its sleep-related effects, which make this drug an attractive therapeutic option for treating patients with COVID-19. The preclinical data suggest that melatonin may inhibit COVID-19 progression. It may lower the risk of the entrance of the SARS-CoV-2 virus into cells, reduce uncontrolled hyper-inflammation and the activation of immune cells, limit the damage of tissues and multiorgan failure due to the action of free radicals, and reduce ventilator-induced lung injury and the risk of disability resulting from fibrotic changes within the lungs. Melatonin may also increase the efficacy of COVID-19 vaccination. The high safety profile of melatonin and its potential anti-SARS-CoV-2 effects make this molecule a preferable drug for treating sleep disturbances in COVID-19 patients. However, randomized clinical trials are needed to verify the clinical usefulness of melatonin in the treatment of COVID-19.

Identifiants

pubmed: 34445329
pii: ijms22168623
doi: 10.3390/ijms22168623
pmc: PMC8395320
pii:
doi:

Substances chimiques

COVID-19 Vaccines 0
Cytokines 0
Free Radical Scavengers 0
Melatonin JL5DK93RCL

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Références

Medicina (Kaunas). 2019 Jul 30;55(8):
pubmed: 31366142
FASEB J. 1998 Oct;12(13):1401-8
pubmed: 9761784
Br J Anaesth. 2011 Aug;107(2):193-201
pubmed: 21659405
Transplant Proc. 2012 May;44(4):962-5
pubmed: 22564597
Int J Mol Sci. 2020 Apr 20;21(8):
pubmed: 32326031
Cell Tissue Res. 2020 Apr;380(1):129-142
pubmed: 31867684
PLoS One. 2020 Oct 2;15(10):e0240149
pubmed: 33006999
Arch Bronconeumol. 2021 Jan;57:66
pubmed: 34629661
J Pineal Res. 2012 Apr;52(3):356-64
pubmed: 21951103
Life Sci. 2018 May 15;201:17-29
pubmed: 29567077
Eur Respir J. 2021 Apr 15;57(4):
pubmed: 33692120
Lancet Psychiatry. 2021 May;8(5):416-427
pubmed: 33836148
BMJ. 2020 Aug 11;370:m3026
pubmed: 32784198
Exp Ther Med. 2021 Mar;21(3):228
pubmed: 33603837
Can J Physiol Pharmacol. 2019 May;97(5):386-391
pubmed: 30673309
J Sleep Res. 2021 Feb;30(1):e13119
pubmed: 32596936
Biomed Pharmacother. 2019 Sep;117:109150
pubmed: 31234024
Int Immunopharmacol. 2018 Sep;62:23-28
pubmed: 29990691
Mod Pathol. 2020 Nov;33(11):2128-2138
pubmed: 32572155
FEBS Lett. 2008 Jan 23;582(2):385-90
pubmed: 18070603
N Engl J Med. 2020 Apr 30;382(18):1708-1720
pubmed: 32109013
Sleep Med. 2020 May;69:127-134
pubmed: 32074506
J Thorac Dis. 2020 Feb;12(Suppl 1):S54-S65
pubmed: 32148926
Exp Lung Res. 2014 Mar;40(2):59-65
pubmed: 24447267
Am J Emerg Med. 2020 Nov;38(11):2444-2454
pubmed: 33039218
Molecules. 2018 Feb 27;23(3):
pubmed: 29495460
Front Immunol. 2020 Jun 16;11:1446
pubmed: 32612617
Psychiatr Pol. 2017 Oct 29;51(5):793-814
pubmed: 29289962
J Pineal Res. 2018 Nov;65(4):e12525
pubmed: 30242884
Psychiatr Pol. 2016;50(1):165-73
pubmed: 27086336
Thorax. 2021 Apr;76(4):405-407
pubmed: 33273028
J Crit Care. 2014 Feb;29(1):184.e9-184.e13
pubmed: 24140166
J Pineal Res. 2014 May;56(4):427-38
pubmed: 24650045
J Pineal Res. 2008 Mar;44(2):127-33
pubmed: 18289163
Int J Mol Sci. 2020 Mar 22;21(6):
pubmed: 32235717
N Engl J Med. 2020 Dec 3;383(23):2255-2273
pubmed: 33264547
Curr Med Res Opin. 2011 Jan;27(1):87-98
pubmed: 21091391
Life Sci. 2020 Jun 1;250:117583
pubmed: 32217117
Rev Recent Clin Trials. 2019;14(3):203-208
pubmed: 31132978
Diseases. 2020 Nov 26;8(4):
pubmed: 33256258
Eur Respir J. 2020 Apr 16;55(4):
pubmed: 32269085
Sleep. 2015 Sep 01;38(9):1353-9
pubmed: 26118561
Trials. 2020 Aug 5;21(1):699
pubmed: 32758298
Front Med (Lausanne). 2020 May 15;7:226
pubmed: 32574327
J Endocrinol. 2012 Aug;214(2):145-53
pubmed: 22619232
J Immunol. 2010 Apr 1;184(7):3487-94
pubmed: 20181888
J Sleep Res. 2020 Aug;29(4):e13052
pubmed: 32246787
Neuro Endocrinol Lett. 2006 Oct;27(5):623-30
pubmed: 17159820
Eur Respir J. 2021 Feb 17;57(2):
pubmed: 33303538
Genes Dev. 2007 Nov 1;21(21):2747-61
pubmed: 17974916
Free Radic Res. 2002 Jul;36(7):727-34
pubmed: 12180122
Int J Hypertens. 2013;2013:521783
pubmed: 23365722
Oncotarget. 2017 Oct 9;8(56):95692-95703
pubmed: 29221159
J Pineal Res. 1999 Mar;26(2):108-12
pubmed: 10100737
Diab Vasc Dis Res. 2020 Mar-Apr;17(3):1479164120920582
pubmed: 32506946
Parasitol Res. 2018 Jun;117(6):1783-1791
pubmed: 29656328
J Pineal Res. 2012 Sep;53(2):154-65
pubmed: 22348531
Curr Top Med Chem. 2002 Feb;2(2):181-97
pubmed: 11899100
Eur J Neurol. 2012 Jan;19(1):155-62
pubmed: 22175760
J Immunol Res. 2015;2015:678164
pubmed: 26417606
Int J Mol Sci. 2013 Apr 11;14(4):7979-99
pubmed: 23579958
FASEB J. 2003 May;17(8):932-4
pubmed: 12670878
Mol Cell Endocrinol. 2020 Mar 1;503:110687
pubmed: 31866317
J Sleep Res. 2017 Dec;26(6):675-700
pubmed: 28875581
J Pineal Res. 2019 Mar;66(2):e12539
pubmed: 30417425
Int J Behav Med. 2021 Feb;28(1):151-158
pubmed: 32236831
Biochim Biophys Acta. 1996 Jun 4;1290(2):191-6
pubmed: 8645723
Ann Am Thorac Soc. 2017 Jun;14(6):844-850
pubmed: 28570160
Pediatr Res. 2001 Dec;50(6):756-60
pubmed: 11726736
Ann Intensive Care. 2020 Mar 18;10(1):33
pubmed: 32189136
J Pineal Res. 2005 Nov;39(4):400-8
pubmed: 16207296
Sleep. 2012 Aug 01;35(8):1063-9
pubmed: 22851802
Int Rev Immunol. 2020;39(4):153-162
pubmed: 32347747
Int J Mol Sci. 2018 Apr 09;19(4):
pubmed: 29642520
Psychiatr Pol. 2017 Oct 29;51(5):815-832
pubmed: 29289963
J Clin Sleep Med. 2015 Oct 15;11(10):1199-236
pubmed: 26414986
Viruses. 2011 Jun;3(6):920-40
pubmed: 21994762
Adv Ther. 2007 Jan-Feb;24(1):91-100
pubmed: 17526465
Ann N Y Acad Sci. 2020 Oct;1478(1):43-62
pubmed: 32700392
Cell. 2020 Apr 16;181(2):271-280.e8
pubmed: 32142651
Rev Med Virol. 2020 May;30(3):e2109
pubmed: 32314850
Thorax. 2020 Nov;75(11):1009-1016
pubmed: 32839287
Sleep Med. 2020 Jun;70:112-115
pubmed: 32361216
J Neuroimmune Pharmacol. 2020 Dec;15(4):572-573
pubmed: 32910359
Circulation. 2020 Jul 14;142(2):184-186
pubmed: 32330083
Am J Respir Crit Care Med. 2020 Jun 1;201(11):1430-1434
pubmed: 32267160
Am J Physiol Lung Cell Mol Physiol. 2008 Nov;295(5):L820-7
pubmed: 18805959
Cell. 2006 Jan 27;124(2):267-73
pubmed: 16439203
J Surg Res. 2016 Aug;204(2):445-451
pubmed: 27565081
Immunobiology. 2014 Dec;219(12):901-8
pubmed: 25161126
Nutrients. 2020 Aug 24;12(9):
pubmed: 32847033
Trials. 2020 Oct 26;21(1):882
pubmed: 33106171
AIMS Neurosci. 2017 Dec 1;5(1):1-17
pubmed: 32341948

Auteurs

Adam Wichniak (A)

Third Department of Psychiatry and Sleep Medicine Center, Institute of Psychiatry and Neurology, 02-957 Warszawa, Poland.

Aleksander Kania (A)

Department of Pulmonology, 2nd Department of Internal Medicine, Faculty of Medicine, Jagiellonian University Medical College, 31-008 Kraków, Poland.

Mariusz Siemiński (M)

Department of Emergency Medicine, Faculty of Medicine, Medical University of Gdańsk, 80-214 Gdańsk, Poland.

Wiesław Jerzy Cubała (WJ)

Department of Psychiatry, Faculty of Medicine, Medical University of Gdańsk, 80-214 Gdańsk, Poland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH